Skip to content

Microbot Medical MBOT EBITDA margin

Discontinued — last reported Q3 '16

EBITDA margin at other companies

Intuitive Surgical logo
Intuitive SurgicalISRG
29.4%+3.0pp
Medtronic logo
MedtronicMDT
25.9%-0.4pp
AngioDynamics logo
AngioDynamicsANGO
-3.9%-1.3pp
ITG
Integer HoldingsITGR
18.3%-0.8pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
20.2%+0.9pp
Stereotaxis logo
StereotaxisSTXS
-66%-14.1pp

Other financials

Income statement

See full
Revenue$105.0K
Gross profit$2.0K
Operating income-$4.3M-43.0%
Net income-$3.7M-41.1%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$3.7M+13.7%
Total debt$898.0K+551%
Total equity$74.1M+156%
Total assets$78.1M+153%

Cash flow

See full
Operating cash flow-$5.1M-75.8%
CapEx$108.0K+731%
Free cash flow-$5.2M-78.8%

Valuation

See full
Market cap$128.28M+36.1%
Enterprise value$125.53M+39.0%
P/S674.3×

Profitability

See full
Operating margin25,292.9%
Net margin-3,669.9%
FCF margin-852.8%

Returns & leverage

See full
Return on equity-27.6%-10.2pp
Debt / equity0.0×
Current ratio22.6×+6.4×

Where this comes from

Calculated from Microbot Medical’s reported figures.

Based on trailing twelve months.

The official record: Microbot Medical’s 10-Q, filed November 14, 2017, on SEC EDGAR. View the filing →

Questions, answered.

What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.